159 related articles for article (PubMed ID: 16139829)
21. Advances in proteomic techniques for biomarker discovery in COPD.
Casado B; Luisetti M; Iadarola P
Expert Rev Clin Immunol; 2011 Jan; 7(1):111-23. PubMed ID: 21162654
[TBL] [Abstract][Full Text] [Related]
22. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory markers in COPD.
Larsson K
Clin Respir J; 2008 Oct; 2 Suppl 1():84-7. PubMed ID: 20298355
[TBL] [Abstract][Full Text] [Related]
24. Relationship between airway colonization, inflammation and exacerbation frequency in COPD.
Tumkaya M; Atis S; Ozge C; Delialioglu N; Polat G; Kanik A
Respir Med; 2007 Apr; 101(4):729-37. PubMed ID: 17002892
[TBL] [Abstract][Full Text] [Related]
25. Nitric oxide and exhaled breath nitrite/nitrates in chronic obstructive pulmonary disease patients.
Liu J; Sandrini A; Thurston MC; Yates DH; Thomas PS
Respiration; 2007; 74(6):617-23. PubMed ID: 17643055
[TBL] [Abstract][Full Text] [Related]
26. Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects.
Malerba M; Ragnoli B; Corradi M
Monaldi Arch Chest Dis; 2008 Sep; 69(3):128-33. PubMed ID: 19065847
[TBL] [Abstract][Full Text] [Related]
27. Consequences of passive smoking in home environment.
Kałucka S
Przegl Lek; 2007; 64(10):632-41. PubMed ID: 18409274
[TBL] [Abstract][Full Text] [Related]
28. [Airway biomarkers in chronic obstructive pulmonary disease].
Tohda Y; Higashimoto Y
Nihon Rinsho; 2011 Oct; 69(10):1802-5. PubMed ID: 22073577
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers of lung damage associated with tobacco smoke in induced sputum.
Comandini A; Rogliani P; Nunziata A; Cazzola M; Curradi G; Saltini C
Respir Med; 2009 Nov; 103(11):1592-613. PubMed ID: 19608395
[TBL] [Abstract][Full Text] [Related]
30. Biomarkers in obstructive respiratory diseases: an update.
Braido F; Bagnasco D; Scichilone N; Santus P; Solidoro P; Di Marco F; Corsico A; Canonica GW
Panminerva Med; 2012 Jun; 54(2):119-27. PubMed ID: 22525566
[TBL] [Abstract][Full Text] [Related]
31. [Role of genetic factors in the development of COPD].
Nishimura M
Nihon Rinsho; 2003 Dec; 61(12):2095-100. PubMed ID: 14674316
[TBL] [Abstract][Full Text] [Related]
32. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
33. [Pathogenesis of chronic obstructive pulmonary disease. Molecular mechanisms (part II)].
Szulakowski P; Mróz RM; Pierzchała W; Chyczewska E; MacNee W
Wiad Lek; 2006; 59(3-4):250-4. PubMed ID: 16813274
[TBL] [Abstract][Full Text] [Related]
34. Functional significance of apoptosis in chronic obstructive pulmonary disease.
Park JW; Ryter SW; Choi AM
COPD; 2007 Dec; 4(4):347-53. PubMed ID: 18027162
[TBL] [Abstract][Full Text] [Related]
35. [Clinical characteristics and condition of the bronchial tree in patients with bronchial asthma and chronic obstructive pulmonary disease in combination with hyperoxaluria].
Fedoseev GB; Petrova MA; Shaĭlieva LO; Kakliugin AP; Zorina ML; Sakharov AN; Pavliukova NO
Ter Arkh; 2007; 79(3):37-41. PubMed ID: 17526194
[TBL] [Abstract][Full Text] [Related]
36. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
37. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
Glader P; von Wachenfeldt K; Löfdahl CG
Respir Med; 2006 Jun; 100(6):1088-93. PubMed ID: 16246539
[TBL] [Abstract][Full Text] [Related]
38. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass.
Ceylan E; Kocyigit A; Gencer M; Aksoy N; Selek S
Respir Med; 2006 Jul; 100(7):1270-6. PubMed ID: 16307872
[TBL] [Abstract][Full Text] [Related]
39. Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients.
Harju TH; Peltoniemi MJ; Rytilä PH; Soini Y; Salmenkivi KM; Board PG; Ruddock LW; Kinnula VL
Respir Res; 2007 Jul; 8(1):48. PubMed ID: 17617905
[TBL] [Abstract][Full Text] [Related]
40. Untargeted lipidomic analysis in chronic obstructive pulmonary disease. Uncovering sphingolipids.
Telenga ED; Hoffmann RF; Ruben t'Kindt ; Hoonhorst SJ; Willemse BW; van Oosterhout AJ; Heijink IH; van den Berge M; Jorge L; Sandra P; Postma DS; Sandra K; ten Hacken NH
Am J Respir Crit Care Med; 2014 Jul; 190(2):155-64. PubMed ID: 24871890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
